The U.S. International Trade Commission (ITC) has issued an order that could potentially bar Apple from importing its Apple Watches. The decision comes after the ITC found that the devices violate the patent rights of medical technology company Masimo.
Specifically, Apple's use of light-based technology for reading blood-oxygen levels infringes on Masimo's rights, according to Bloomberg.
Presidential Review and Possible Appeals Await the Decision
Reuters reported that while the ITC ruling will not have an immediate effect, it now faces review by President Joe Biden's administration. The administration will have 60 days to determine whether to veto the import ban based on policy concerns before it goes into effect.
It is worth noting that presidents rarely veto bans in these circumstances. Additionally, Apple can appeal the ban to the U.S. Court of Appeals for the Federal Circuit after the review period ends.
Masimo Chief Executive Officer Joe Kiani has expressed satisfaction with the ruling, stating that it "sends a powerful message that even the world's largest company is not above the law."
The ITC decision, however, did not specify which models of Apple Watches would be affected by the ban. Masimo's original complaint mentioned that the 2020 Apple Watch Series 6, which introduced blood-oxygen monitoring capabilities, infringed on its patents.
Intellectual Property Fight Between Apple and Masimo
The dispute between Apple and Masimo spans several jurisdictions and began with Masimo accusing Apple of stealing its technology and incorporating it into multiple Apple Watch models. In May, a jury trial on Masimo's allegations in a California federal court ended with a mistrial.
In addition to the ITC case, Apple has separately sued Masimo for patent infringement in federal court in Delaware. Apple claims that Masimo's legal actions are a tactical move to clear the path for its competing smartwatch.
Apple is also involved in a patent dispute with medical technology company AliveCor, which has led to an ITC-issued ban on Apple Watch imports. However, the ban is currently on hold during related proceedings concerning the validity of AliveCor's patents.
According to a company report, Apple's wearables, home, and accessory business, including the Apple Watch, AirPods earbuds, and other products, produced an impressive revenue of $8.28 billion in the third quarter of 2023.
Photo: Sophia Stark/Unsplash


Nike Shifts China Online Sales Strategy to Boost Brand and Fight Local Rivals
ASML Trillion-Dollar Valuation: Can Europe’s AI Chip Giant Reach the Historic Milestone?
GM Q2 Earnings Beat Estimates as General Motors Raises 2026 Profit Outlook
Foxconn Wins First SpaceX AI Server Contract Worth Estimated $52 Billion
DeepSeek Eyes $74 Billion Valuation Ahead of Planned China IPO
Super Micro Computer Stock Jumps 20% After Record AI Orders and Margin Surge
Judge Approves Anthropic’s $1.5 Billion AI Copyright Settlement With Authors
Apple Intelligence China Approval Lifts Alibaba and Baidu Shares
US, China to Hold AI Talks Ahead of Xi’s September Visit
Xi Jinping Calls for People-Centered AI Development at WAIC, Expands Global Cooperation
KAIST, Stanford Develop Self-Dressing Robot for Cleanrooms and Emergency Gear
SpaceX Targets Thursday Launch for Starship's 13th Test Flight After Last-Minute Delay
Nvidia Reveals 9.3% Stake in AI Cloud Firm Nebius Following $2 Billion Investment
Chalco Shares Jump as Chinalco Plans Up to $300 Million Stake Increase
Tesla Stock Outlook: Strong EV Sales Boost Earnings, but AI Projects Drive Long-Term Value
Jamie Dimon Warns Anthropic's Mythos AI Poses National Security Risks
Alaska Air Q3 Outlook Misses Estimates as Higher Fuel Costs Weigh on Profit Forecast 



